Therapeutics Exam 2 (Supportive Care) Flashcards
(283 cards)
What is the most feared complication of chemotherapy?
Chemotherapy Induced Nausea and Vomiting (CNV)
What are the 5 types of Nausea/Vomiting?
Anticipatory
Acute
Delayed
Breakthrough
Refractory
What is anticipatory nausea/vomiting?
-A learned response conditioned by previous emetic reactions from prior cycles of chemotherapy
-Can be provoked by sight, sound, or smell
What is acute nausea/vomiting?
-Emetic response that correlates with the administration of chemotherapy
within 24 hours of receiving chemotherapy
What is delayed nausea/vomiting?
-Related to chemotherapy but occurs >24 hours after completion
What is breakthrough nausea/vomiting?
Occurs even though the patient is on scheduled anti-emetics prior to chemotherapy
What is refractory nausea/vomiting?
Persists despite appropriate anti-emetic therapy
-Patient has failed other therapies at this point
How does chemotherapy cause CINV?
It begins in the GI tract where cytotoxic chemotherapy induces damage to epithelial cells lining the GI tract
Enterochromaffin cells that line the GI tract contain large amounts of serotonin which is released in massive quantities
The chemoreceptor trigger zone (CTZ) stimulates the vomiting center (located in the medulla)
Input to the vomiting center from higher cortical centers such as the pharynx and GI tract induce emesis
Which cells are responsible for the massive release of serotonin in the GI tract after chemotherapy that leads to CINV?
Enterochromaffin cells
Which neurotransmitter can be targeted to treat breakthrough CINV?
Dopamine
What are the 2 most commonly targeted neurotransmitters for treatment of CINV?
Serotonin
Substance P
Which receptor mediates the action of substance P?
neurokinin-1 receptor
Which chemotherapy produces the most nausea?
Cisplatin
How does the combination of chemotherapies affect emetogenicity?
Level 1 and 2 agents do not contribute to the regimen’s emetogenicity
Level 3 and 4 agents increase the emetogenicity of the combination regimen by 1 level per agent
Who is at a higher risk for CINV: Men or Women?
Women
Who is at a higher risk for CINV: Younger Patients or Older Patients
Younger Patients
What are 4 risk factors of CINV?
Prior history of motion sickness
Prior history of morning sickness
Previous CINV
Anxiety/high pretreatment anticipation of nausea
What trait can be protective against CINV?
Chronic ethanol use
How do we decide what prophylaxis to use for acute nausea and vomiting?
It is based on the emetogenic potential of the chemotherapy
Which is more efficacious: Oral or IV CINV prophylaxis
NEITHER, their are equally effective
How many highly emetogenic regimens exist for acute N/V?
3
What are the 4 types of drugs included in the acute N/V highly emetogenic regimen A?
NK-1 Antagonist (“tant”)
(Aprepitant, Fosaprepitant, Rolapitant, Netupitant/palonosetron, Fosnetupitant/palonosetron)
Steroid
(Dexamethasone)
5-HT3 Antagonist (“setron”)
(Dolasetron, Granisetron, Ondansetron, Palonosetron)
Atypical Antipsychotic
(Olanzapine)
What are the 3 types of drugs included in the acute N/V highly emetogenic regimen B?
Atypical Antipsychotic
(Olanzapine)
Steroid
(Dexamethasone)
5-HT3 Antagonist
(Palonosetron)
What are the 3 types of drugs included in the acute N/V highly emetogenic regimen C?
NK-1 antagonist
(“tant”)
Steroid
(Dexamethasone)
5-HT3 Antagonist
(“setron”)